BTG4 Antibodies

Santa Cruz Biotechnology provides a broad selection of BTG4 monoclonal antibodies for research focused on understanding BTG4 protein functions. BTG4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BTG4, or B-cell translocation gene 4, is a critical regulator of cell proliferation and differentiation, playing a significant role in the control of the cell cycle. BTG4 is involved in the modulation of gene expression and has been linked to various cellular processes, including apoptosis and tumor suppression. Understanding BTG4 function is essential for elucidating its potential impact on cancer biology and therapeutic strategies. Research has shown that BTG4 expression patterns vary across different tissue types and developmental stages. BTG4 has emerged as a promising target for cancer research due to its tumor suppressor properties. Recent studies have highlighted BTG4's role in cell cycle regulation and its potential implications in various pathological conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of BTG4's role in cellular processes and disease mechanisms.